OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities

Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Gastric Cancer
January 19, 2020
Clarification on News Article by Economy Daily News
March 12, 2020

1.Date of the event: Mar 11, 2020
2.Time: 14:30:00 NST
3.Location: Taipei New Horizon (Address: 6F., No. 88, Yanchang Rd., Xinyi Dist., Taipei City 110, Taiwan)
4.Summary: OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities
5.Any other matters that need to be specified: None
Please refer to MOPS for detail financial information regarding the event.